Related Experiment Video
Updated: Jul 15, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Endothelial Dysfunction and Cardiovascular Risk in Obstructive Sleep Apnea: A Review Article
Miriam Peracaula1, Daniela Torres1, Paula Poyatos1
1Department of Pulmonary Medicine, Dr. Josep Trueta University Hospital of Girona, Santa Caterina Hospital de Salt and the Girona Biomedical Research Institute (IDIBGI), 17190 Girona, Spain.
Obstructive sleep apnea (OSA) affects many but is underdiagnosed. This condition causes endothelial dysfunction, increasing cardiovascular disease risk, and new biomarkers are needed for diagnosis and treatment.
Area of Science:
- Cardiology
- Pulmonology
- Sleep Medicine
Background:
- Obstructive sleep apnea (OSA) is a prevalent respiratory disorder characterized by repeated upper airway obstruction during sleep.
- Despite affecting 30% of the population, OSA remains underdiagnosed due to vague symptoms and inadequate screening tools.
- OSA is linked to endothelial dysfunction, triggering various physiological responses including hypoxia, hypercapnia, and oxidative stress.
Purpose of the Study:
- To review the relationship between OSA and endothelial dysfunction.
- To explore the association between OSA, endothelial dysfunction, and cardiovascular pathologies like hypertension.
- To define current treatments, their limitations, and future research directions in OSA.
Main Methods:
- Literature review of studies investigating OSA, endothelial dysfunction, and cardiovascular disease.
- Analysis of biological responses associated with OSA, including hypoxia and oxidative stress.
- Examination of clinical features and potential biomarkers for OSA diagnosis and therapy.
Main Results:
- OSA is associated with endothelial dysfunction, leading to increased cardiovascular disease risk.
- Hypertension is a common cardiovascular pathology linked to OSA.
- Endothelial progenitor cell alterations are identified as potential biomarkers.
Conclusions:
- OSA significantly contributes to endothelial dysfunction and cardiovascular morbidity.
- Improved diagnostic tools and targeted therapies are needed for effective OSA management.
- Further research into biomarkers like endothelial progenitor cells could enhance early diagnosis and treatment strategies.
More Related Videos
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Sleep Apnea
The condition is more prevalent among...
Coronary Artery Disease I: Introduction
Hypertension II: Pathophysiology